Chung-Wein Lee

Title: Innovations in Photoimmunotherapy by Chung-Wein Lee

Introduction

Chung-Wein Lee is a notable inventor based in San Diego, CA. He has made significant contributions to the field of photoimmunotherapy, particularly through his innovative methods and applications. His work focuses on enhancing the efficacy of cancer treatments by utilizing biomarkers.

Latest Patents

Chung-Wein Lee holds a patent for "Methods for photoimmunotherapy and related biomarkers." This patent involves methods that utilize biomarkers in conjunction with photoimmunotherapy. The techniques include the activation of a phthalocyanine dye conjugated to a targeting molecule that binds to proteins on tumor cells, such as an IR700-antibody conjugate. The patent also discusses combination therapies that incorporate photoimmunotherapy alongside additional therapeutic agents, including immune modulating agents. These methods aim to identify subjects suitable for photoimmunotherapy and assess their likelihood of responding to treatment. The innovations provide various advantages, including improved efficacy and the potential for personalized medicine.

Career Highlights

Chung-Wein Lee is currently associated with Rakuten Medical, Inc., where he continues to advance his research and development in the field of cancer therapies. His work is pivotal in the ongoing quest for more effective treatment options for tumors and cancers.

Collaborations

Chung-Wein Lee collaborates with esteemed colleagues, including Miguel Garcia-Guzman and Roger Heim. Their combined expertise contributes to the innovative approaches being developed in the realm of photoimmunotherapy.

Conclusion

Chung-Wein Lee's contributions to photoimmunotherapy represent a significant advancement in cancer treatment methodologies. His innovative approaches and patented methods hold promise for improving patient outcomes and personalizing therapeutic regimens.